COVID-19
UK Government Extends Authorization for Innova Medical SARS-CoV-2 Antigen Test
The UK government has extended the timeline of its Exceptional Use Authorization for the Innova lateral flow test, though the FDA has warned about its performance.
Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test
The Cobas test is the first molecular, point-of-care test to receive Emergency Use Authorization for asymptomatic people.
Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test
SARS-CoV-2 testing has become a major part of Co-Diagnostics' business, accounting for the lion's share of the company's revenues recently.
LumiraDx Gets CE Mark for POC, Pooled Sample SARS-CoV-2 Antigen Test
The company last year received FDA Emergency Use Authorization for a PCR-based SARS-CoV-2 that does not require nucleic acid purification or extraction.
The tool combines geographical data on viral mutations with an easy-to-use interface to check whether primers may be affected.
Jun 16, 2021
Angstrom Bio Raises $3M in Private Financing
Jun 16, 2021
Jun 16, 2021
SQI Diagnostics Raises C$3.9M From Warrant Exercise
Jun 15, 2021
Actim Gets CE Mark for Rapid SARS-CoV-2 Antigen Test
Jun 11, 2021
Avacta Obtains CE Mark for SARS-CoV-2 Antigen Test
Jun 10, 2021